Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Effect of Sarcopenia on the Efficacy and Prognosis of HCC Treated With Systemic Therapies

Authors not listed

First Affiliated Hospital of Wenzhou Medical University · 2022

Abstract

Sarcopenia is associated with the prognosis of HCC and cholangiocarcinoma. But there has been rare study focusing on the effect of sarcopenia on the prognosis of HCC treated with systemic therapy, such as interventional therapy, targeted therapy, chemotherapy and immunotherapy and so on.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-05 MST

Cite this

APA
Anonymous. (2022). Effect of Sarcopenia on the Efficacy and Prognosis of HCC Treated With Systemic Therapies. <em>First Affiliated Hospital of Wenzhou Medical University</em>. https://clinicaltrials.gov/study/NCT05448222
Vancouver
Anonymous. Effect of Sarcopenia on the Efficacy and Prognosis of HCC Treated With Systemic Therapies. First Affiliated Hospital of Wenzhou Medical University. 2022.
BibTeX
@misc{anon2022Effect, title = {Effect of Sarcopenia on the Efficacy and Prognosis of HCC Treated With Systemic Therapies}, author = {Anonymous}, journal = {First Affiliated Hospital of Wenzhou Medical University}, year = {2022}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings